Cite
HARVARD Citation
Hoffknecht, P. et al. (2015). Efficacy of the Irreversible ErbB Family Blocker Afatinib in Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI)–Pretreated Non–Small-Cell Lung Cancer Patients with Brain Metastases or Leptomeningeal Disease. Journal of thoracic oncology. 10 (1), p. . [Online].